This site is intended for healthcare professionals

Positive results from randomized controlled trial of CP1 01, an oral microbiome drug, for the prevention of recurrent C. difficile infection.-Finch Therapeutics Group

Read time: 1 mins
Last updated:23th Jun 2020
Published:21th Jun 2020
Condition: Infectious Diseases/Clostridium
Type: drug
Register free for full access to